These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 2872726

  • 21. [The immunosuppressive agents in rheumatology. Indications, results and problems of long-term surveillance].
    Kahn MF, De Seze S.
    Ann Med Interne (Paris); 1974; 125(6-7):497-506. PubMed ID: 4216281
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The clinical use of immunosuppressive drugs.
    Forbes IJ.
    Med J Aust; 1973 Apr 14; 1(15):749-52. PubMed ID: 4707372
    [No Abstract] [Full Text] [Related]

  • 24. Treatment of rheumatoid arthritis with cytostatic drugs.
    Lorenzen I.
    Ann Clin Res; 1975 Jun 14; 7(3):195-201. PubMed ID: 1103713
    [No Abstract] [Full Text] [Related]

  • 25. [Long-term treatment with imuran and methotrexate in rheumatoid conditions].
    Wysocka K, Petrus B.
    Reumatologia; 1972 Jun 14; 10(1):35-41. PubMed ID: 4401687
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Methotrexate: its use in the rheumatic diseases.
    Bookbinder SA, Espinoza LR, Fenske NA, Germain BF, Vasey FB.
    Clin Exp Rheumatol; 1984 Jun 14; 2(2):185-93. PubMed ID: 6398173
    [Abstract] [Full Text] [Related]

  • 31. Cyclophosphamide pulses in the treatment of rheumatic diseases: an update.
    De Vita S, Neri R, Bombardieri S.
    Clin Exp Rheumatol; 1991 Jun 14; 9(2):179-93. PubMed ID: 2060164
    [No Abstract] [Full Text] [Related]

  • 32. Comparative toxicity of total lymphoid irradiation and immunosuppressive drug treated patients with intractable rheumatoid arthritis.
    Sherrer Y, Bloch D, Strober S, Fries J.
    J Rheumatol; 1987 Feb 14; 14(1):46-51. PubMed ID: 3572934
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Complications and sequelae of immunosuppressive therapy of rheumatoid arthritis].
    Deshayes P, Rénier JC, Bregeon C, Houdent G.
    Rev Rhum Mal Osteoartic; 1971 Dec 14; 38(12):797-806. PubMed ID: 5170383
    [No Abstract] [Full Text] [Related]

  • 35. Efficacy of immunosuppressive drugs in rheumatic diseases.
    Steinberg AD.
    Arthritis Rheum; 1973 Dec 14; 16(1):92-6. PubMed ID: 4540291
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Practical use of immunosuppressive drugs in autoimmune rheumatic diseases.
    De Jesus A, Talal N.
    Crit Care Med; 1990 Feb 14; 18(2 Suppl):S132-7. PubMed ID: 2298028
    [Abstract] [Full Text] [Related]

  • 38. Cytostatic drugs in the treatment of severe vasculitides. Indications, results and risks.
    Kaeser HE.
    Eur Neurol; 1984 Feb 14; 23(6):407-9. PubMed ID: 6150853
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Current problems of immunology and immunosuppressive therapy in rheumatic diseases].
    Vorlaender KO.
    Clin Ter; 1967 Jul 15; 42(1):3-14. PubMed ID: 4386113
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.